United States securities and exchange commission logo




                                                                                
                          May 31, 2024

       James V. Caruso
       President and Chief Executive Officer
       Cellectar Biosciences, Inc.
       100 Campus Drive
       Florham Park, New Jersey 07932

                                                        Re: Cellectar 
Biosciences, Inc.
                                                            Registration 
Statement on Form S-3
                                                            Filed May 24, 2024
                                                            File No. 333-279731

       Dear James V. Caruso:

              This is to advise you that we have not reviewed and will not 
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for 
acceleration. We remind you
       that the company and its management are responsible for the accuracy and 
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of 
action by the staff.

                                                        Please contact Tim 
Buchmiller at 202-551-3635 with any questions.



                                                                                
                          Sincerely,

                                                                                
                          Division of Corporation Finance
                                                                                
                          Office of Life Sciences
       cc:                                              Asher M. Rubin, Esq.